Grades of Diabetic Ketoacidosis
Diabetic ketoacidosis is classified into three severity grades based on venous pH: mild (pH 7.20-7.30), moderate (pH 7.10-7.20), and severe (pH <7.10), with corresponding bicarbonate and clinical criteria that guide treatment intensity and level of care.
Severity Classification Criteria
The standard grading system for DKA uses multiple biochemical parameters 1, 2:
Mild DKA
- Venous pH: 7.20-7.30 (or <7.30 in some classifications) 1
- Serum bicarbonate: 15-18 mmol/L 1
- Anion gap: >10 mmol/L
- Serum glucose: ≥200 mg/dL (11.1 mmol/L) 1
- Mental status: Alert 2
Moderate DKA
- Venous pH: 7.10-7.20 1, 2
- Serum bicarbonate: 10-15 mmol/L 1
- Anion gap: >12 mmol/L
- Serum glucose: ≥200 mg/dL (11.1 mmol/L) 1
- Mental status: Alert or drowsy 2
Severe DKA
- Venous pH: <7.10 1, 2
- Serum bicarbonate: <10 mmol/L 1
- Anion gap: >12 mmol/L
- Serum glucose: ≥200 mg/dL (11.1 mmol/L) 1
- Mental status: Altered mental status or stupor/coma 3, 2
Alternative Ketone-Based Markers
When beta-hydroxybutyrate (BHB) is measured, corresponding severity thresholds are 4:
- Mild DKA: Serum BHB ~4.5 mmol/L
- Moderate DKA: Serum BHB ~5.7 mmol/L
- Severe DKA: Serum BHB ~5.9 mmol/L
Treatment Implications by Severity
Moderate-to-severe DKA requires continuous intravenous insulin infusion, while mild-to-moderate DKA may be managed with frequent subcutaneous insulin injections 5. Severe cases (pH ≤7.00) with altered mental status require ICU-level care 3.
Resolution Criteria
DKA resolution is defined as 1:
- Venous pH ≥7.30 AND
- Anion gap ≤18 mmol/L OR
- Serum bicarbonate >15 mmol/L (76% sensitivity, 85% specificity) 1
- Serum BHB <1 mmol/L (73.7% sensitivity, 100% specificity) 4
Important Clinical Caveats
The anion gap closes at different times relative to pH normalization depending on severity: in mild DKA, the anion gap closes after pH normalizes, whereas in moderate and severe DKA, the anion gap closes before pH normalizes 1. This means you cannot rely on anion gap alone to determine resolution in severe cases.
Hypokalaemia occurs in approximately 50% of patients during DKA treatment, and severe hypokalaemia (<2.5 mEq/L) is associated with increased mortality, necessitating careful potassium monitoring throughout treatment 5.
In resource-limited settings where venous blood gas is unavailable, serum bicarbonate >15 mmol/L alone can reliably predict DKA resolution 1.